Janus Kinase Inhibitor [EPC]

Janus Kinase Inhibitor [EPC] was reported 160751 times

Drugs of the Janus Kinase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 OSTOMY BAG PLACEMENT 141 0.3140
1 ECZEMA HERPETICUM 145 0.3132
2 MYELOFIBROSIS 947 0.3129
3 PRIMARY MYELOFIBROSIS 97 0.3012
4 SEMEN DISCOLOURATION 87 0.2843
5 HAEMATOCRIT ABNORMAL 326 0.2650
6 MYELOPROLIFERATIVE NEOPLASM 132 0.1991
7 STOMA CREATION 134 0.1931
8 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 105 0.1872
9 DISEASE RISK FACTOR 71 0.1766
10 POLYCYTHAEMIA VERA 133 0.1624
11 GRAFT VERSUS HOST DISEASE IN LIVER 115 0.1606
12 BLAST CELLS PRESENT 77 0.1601
13 SPLENOMEGALY 1832 0.1562
14 HAEMATOCRIT INCREASED 350 0.1534
15 GRAFT VERSUS HOST DISEASE IN LUNG 68 0.1423
16 INTESTINAL ANASTOMOSIS 90 0.1398
17 PLATELET COUNT ABNORMAL 814 0.1345
18 BLOOD LACTATE DEHYDROGENASE ABNORMAL 87 0.1283
19 PLATELET COUNT INCREASED 1656 0.1269
20 ILEOSTOMY 305 0.1194
21 SPLEEN DISORDER 201 0.1186
22 RED BLOOD CELL COUNT ABNORMAL 167 0.1136
23 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 74 0.1128
24 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 103 0.1112
25 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 231 0.1085
26 PRODUCT RESIDUE PRESENT 572 0.1060
27 IRON OVERLOAD 110 0.1019
28 MEDICAL DEVICE IMPLANTATION 158 0.1006
29 SHOULDER ARTHROPLASTY 263 0.0976
30 GRAFT VERSUS HOST DISEASE IN SKIN 209 0.0948
31 CHRONIC GRAFT VERSUS HOST DISEASE 342 0.0946
32 HAEMOGLOBIN ABNORMAL 609 0.0946
33 SPINAL OPERATION 1115 0.0904
34 PRODUCT AVAILABILITY ISSUE 2040 0.0895
35 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 116 0.0881
36 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 124 0.0878
37 BLAST CELL COUNT INCREASED 87 0.0830
38 CUTANEOUS T-CELL LYMPHOMA 103 0.0817
39 EARLY SATIETY 151 0.0775
40 SUPERFICIAL VEIN THROMBOSIS 65 0.0772
41 MEDICAL PROCEDURE 128 0.0769
42 NECK SURGERY 179 0.0768
43 FULL BLOOD COUNT INCREASED 91 0.0764
44 BLOOD COUNT ABNORMAL 1157 0.0762
45 SHOULDER OPERATION 323 0.0755
46 GRAFT VERSUS HOST DISEASE 540 0.0750
47 COLECTOMY 418 0.0739
48 LIPIDS INCREASED 148 0.0733
49 KNEE OPERATION 721 0.0732
50 WHITE BLOOD CELL COUNT ABNORMAL 464 0.0726
51 LIMB OPERATION 347 0.0723
52 ANKLE OPERATION 106 0.0717
53 KNEE ARTHROPLASTY 1497 0.0710
54 WRIST SURGERY 66 0.0706
55 HAEMOGLOBIN INCREASED 319 0.0699
56 FOOT OPERATION 341 0.0688
57 NEUROENDOCRINE CARCINOMA OF THE SKIN 66 0.0674
58 JOINT ARTHROPLASTY 119 0.0664
59 ARTHRODESIS 67 0.0658
60 HIP SURGERY 346 0.0639
61 SQUAMOUS CELL CARCINOMA OF SKIN 381 0.0630
62 SMALL INTESTINAL RESECTION 73 0.0626
63 INTERVERTEBRAL DISC OPERATION 76 0.0612
64 ADENOVIRUS INFECTION 177 0.0610
65 DENTAL OPERATION 150 0.0608
66 POST PROCEDURAL SWELLING 66 0.0601
67 ACUTE LEUKAEMIA 97 0.0600
68 RED BLOOD CELL COUNT INCREASED 165 0.0598
69 BONE MARROW DISORDER 178 0.0589
70 SPINAL FUSION SURGERY 237 0.0584
71 ORAL SURGERY 134 0.0572
72 HIP ARTHROPLASTY 872 0.0569
73 CYTOMEGALOVIRUS INFECTION REACTIVATION 248 0.0561
74 DECREASED ACTIVITY 605 0.0560
75 THROMBOCYTOSIS 204 0.0556
76 OPHTHALMIC HERPES ZOSTER 100 0.0554
77 X-RAY ABNORMAL 97 0.0542
78 SQUAMOUS CELL CARCINOMA 509 0.0540
79 SHOULDER FRACTURE 88 0.0538
80 ROTATOR CUFF REPAIR 94 0.0536
81 GASTROINTESTINAL WALL THICKENING 80 0.0534
82 INTESTINAL OPERATION 84 0.0530
83 JOINT NOISE 104 0.0529
84 POST HERPETIC NEURALGIA 75 0.0522
85 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 108 0.0521
86 LARGE INTESTINE INFECTION 64 0.0520
87 NOROVIRUS INFECTION 74 0.0512
88 STENOSIS 96 0.0511
89 COLOSTOMY 100 0.0509
90 ACUTE GRAFT VERSUS HOST DISEASE 232 0.0506
91 DISLOCATION OF VERTEBRA 115 0.0504
92 SKIN CANCER 1080 0.0501
93 SPINAL STENOSIS 205 0.0496
94 FAECAL CALPROTECTIN INCREASED 157 0.0495
95 BLOOD IRON INCREASED 90 0.0479
96 INFLAMMATORY MARKER INCREASED 234 0.0472
97 SURGERY 2766 0.0471
98 INVESTIGATION ABNORMAL 67 0.0466
99 DENTAL IMPLANTATION 75 0.0458
100 BASAL CELL CARCINOMA 712 0.0456
101 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 122 0.0441
102 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 327 0.0435
103 PRECANCEROUS SKIN LESION 64 0.0434
104 INCREASED TENDENCY TO BRUISE 392 0.0426
105 WHITE BLOOD CELL COUNT INCREASED 1583 0.0412
106 GRIP STRENGTH DECREASED 357 0.0405
107 VARICELLA ZOSTER VIRUS INFECTION 84 0.0405
108 JOINT RANGE OF MOTION DECREASED 538 0.0401
109 PULMONARY THROMBOSIS 432 0.0396
110 EMBOLISM VENOUS 120 0.0395
111 LARGE INTESTINAL HAEMORRHAGE 87 0.0387
112 POST PROCEDURAL INFECTION 311 0.0382
113 RED BLOOD CELL COUNT DECREASED 1090 0.0381
114 EYE OPERATION 175 0.0379
115 RHEUMATIC DISORDER 73 0.0377
116 INFECTION SUSCEPTIBILITY INCREASED 82 0.0374
117 PRODUCT DISTRIBUTION ISSUE 347 0.0374
118 SPLENIC INFARCTION 65 0.0372
119 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 98 0.0368
120 FULL BLOOD COUNT ABNORMAL 388 0.0366
121 SPONDYLITIS 133 0.0365
122 MENISCUS INJURY 223 0.0362
123 PLATELET DISORDER 91 0.0361
124 HERPES SIMPLEX 233 0.0358
125 PUSTULAR PSORIASIS 123 0.0358
126 RASH VESICULAR 172 0.0355
127 HERPES ZOSTER 2023 0.0352
128 TRIGGER FINGER 142 0.0347
129 APPENDICECTOMY 123 0.0344
130 HAEMOGLOBIN DECREASED 3529 0.0343
131 LEUKAEMIA 324 0.0343
132 IMMUNODEFICIENCY 509 0.0341
133 BK VIRUS INFECTION 115 0.0341
134 CARTILAGE INJURY 84 0.0340
135 CYTOPENIA 411 0.0335
136 LARGE INTESTINAL STENOSIS 66 0.0330
137 BLOOD IRON DECREASED 391 0.0329
138 IMMUNOSUPPRESSION 287 0.0325
139 WHITE BLOOD CELL DISORDER 87 0.0325
140 GALLBLADDER OPERATION 130 0.0321
141 SWOLLEN JOINT COUNT INCREASED 102 0.0320
142 RHEUMATOID ARTHRITIS 3626 0.0319
143 INTESTINAL RESECTION 171 0.0318
144 HAEMATOLOGICAL INFECTION 77 0.0315
145 MUSCULOSKELETAL DISORDER 596 0.0313
146 DYSCHEZIA 94 0.0308
147 SECOND PRIMARY MALIGNANCY 255 0.0306
148 ABSCESS INTESTINAL 66 0.0306
149 GENERAL SYMPTOM 228 0.0304
150 POSTOPERATIVE WOUND INFECTION 205 0.0303
151 BACK DISORDER 491 0.0302
152 ARTHRITIS INFECTIVE 140 0.0302
153 PNEUMONIA FUNGAL 119 0.0301
154 HYSTERECTOMY 261 0.0301
155 MALABSORPTION 157 0.0300
156 RETINAL TEAR 74 0.0300
157 JOINT LOCK 85 0.0299
158 ACNE CYSTIC 90 0.0299
159 HAEMATOCRIT DECREASED 591 0.0298
160 FULL BLOOD COUNT DECREASED 596 0.0295
161 WALKING AID USER 194 0.0294
162 THERAPY INTERRUPTED 2096 0.0293
163 ROTATOR CUFF SYNDROME 371 0.0289
164 OBSTRUCTION 114 0.0285
165 HERPES VIRUS INFECTION 160 0.0277
166 RHINOVIRUS INFECTION 108 0.0277
167 LUNG OPACITY 73 0.0277
168 FOOT DEFORMITY 306 0.0276
169 WOUND HAEMORRHAGE 102 0.0276
170 CARPAL TUNNEL SYNDROME 386 0.0275
171 ACUTE MYELOID LEUKAEMIA 429 0.0275
172 BLOOD CHOLESTEROL INCREASED 1283 0.0275
173 NIGHT SWEATS 885 0.0274
174 FOLLICULITIS 288 0.0274
175 PLATELET COUNT DECREASED 2915 0.0273
176 CYTOMEGALOVIRUS VIRAEMIA 121 0.0272
177 PUSTULE 64 0.0270
178 RED CELL DISTRIBUTION WIDTH INCREASED 111 0.0267
179 RESPIRATORY SYNCYTIAL VIRUS INFECTION 232 0.0266
180 LUMBAR SPINAL STENOSIS 77 0.0263
181 LIGAMENT RUPTURE 116 0.0262
182 INTERVERTEBRAL DISC PROTRUSION 572 0.0261
183 OSTEOARTHRITIS 1102 0.0260
184 SKIN PAPILLOMA 104 0.0259
185 ENERGY INCREASED 152 0.0257
186 COVID-19 PNEUMONIA 302 0.0256
187 SYNOVIAL CYST 118 0.0255
188 NERVE COMPRESSION 235 0.0254
189 ASPERGILLUS INFECTION 167 0.0254
190 GASTRIC INFECTION 97 0.0253
191 ABSCESS LIMB 108 0.0253
192 COLITIS ULCERATIVE 1130 0.0253
193 SERUM FERRITIN INCREASED 133 0.0252
194 REHABILITATION THERAPY 97 0.0250
195 COVID-19 4395 0.0250
196 RENAL FUNCTION TEST ABNORMAL 116 0.0250
197 BLOOD CHOLESTEROL ABNORMAL 115 0.0249
198 BLOOD DISORDER 198 0.0247
199 DISEASE COMPLICATION 113 0.0247
200 SARS-COV-2 TEST POSITIVE 326 0.0247
201 ROSACEA 115 0.0247
202 IRON DEFICIENCY 111 0.0247
203 ACNE 1860 0.0245
204 FIBRIN D DIMER INCREASED 87 0.0245
205 ORAL HERPES 474 0.0243
206 PELVIC FRACTURE 188 0.0241
207 GAIT INABILITY 800 0.0239
208 THERAPEUTIC PRODUCT EFFECT DECREASED 1070 0.0239
209 HAEMORRHAGIC DIATHESIS 85 0.0238
210 INTESTINAL STENOSIS 100 0.0237
211 LARGE INTESTINAL ULCER 64 0.0236
212 FUNGAL SKIN INFECTION 95 0.0235
213 MALIGNANT MELANOMA 315 0.0235
214 RHEUMATIC FEVER 104 0.0233
215 GENERAL PHYSICAL CONDITION ABNORMAL 158 0.0233
216 BRONCHOPULMONARY ASPERGILLOSIS 180 0.0232
217 INFLAMMATION 1197 0.0232
218 FINGER DEFORMITY 112 0.0231
219 JOINT EFFUSION 159 0.0230
220 PNEUMOCYSTIS JIROVECII PNEUMONIA 230 0.0229
221 SEBORRHOEA 84 0.0228
222 HEPATOMEGALY 223 0.0227
223 MELANOCYTIC NAEVUS 99 0.0226
224 GASTROINTESTINAL PERFORATION 93 0.0223
225 DIVERTICULITIS 619 0.0223
226 RETINAL DETACHMENT 204 0.0222
227 INTESTINAL PERFORATION 249 0.0222
228 STAPHYLOCOCCAL BACTERAEMIA 96 0.0221
229 CONTUSION 2126 0.0221
230 ILLNESS 2269 0.0220
231 CYST 273 0.0220
232 DEFAECATION URGENCY 154 0.0220
233 SCIATICA 350 0.0219
234 CYTOMEGALOVIRUS INFECTION 364 0.0219
235 LABORATORY TEST ABNORMAL 641 0.0217
236 SKIN DISORDER 724 0.0217
237 PNEUMONIA VIRAL 69 0.0216
238 BLOOD URIC ACID INCREASED 124 0.0215
239 GOUT 385 0.0214
240 CYSTITIS HAEMORRHAGIC 86 0.0213
241 TIBIA FRACTURE 100 0.0213
242 HORDEOLUM 92 0.0212
243 CATARACT 1264 0.0212
244 ARTHRITIS BACTERIAL 87 0.0212
245 INTERVERTEBRAL DISC DEGENERATION 196 0.0212
246 CHEMOTHERAPY 80 0.0211
247 MUSCLE RUPTURE 82 0.0210
248 PRODUCT DOSE OMISSION 1374 0.0210
249 THROMBOTIC MICROANGIOPATHY 204 0.0209
250 LOCALISED INFECTION 506 0.0209
251 BLOOD TEST ABNORMAL 291 0.0207
252 EXOSTOSIS 189 0.0207
253 ANAEMIA 3934 0.0206
254 ANAL FISTULA 110 0.0206
255 MUSCLE STRAIN 178 0.0206
256 TENDON RUPTURE 253 0.0205
257 DERMATITIS ATOPIC 1080 0.0205
258 WOUND INFECTION 223 0.0203
259 JOINT DISLOCATION 215 0.0203
260 PLANTAR FASCIITIS 68 0.0203
261 RHEUMATOID FACTOR POSITIVE 117 0.0202
262 HAEMATOTOXICITY 192 0.0202
263 PRODUCT DOSE OMISSION IN ERROR 571 0.0201
264 PORTAL VEIN THROMBOSIS 65 0.0201
265 ARTHROPATHY 1118 0.0201
266 IMPAIRED HEALING 659 0.0201
267 ANAL ABSCESS 107 0.0198
268 ONYCHOMYCOSIS 87 0.0198
269 PNEUMONIA BACTERIAL 182 0.0198
270 WOUND COMPLICATION 68 0.0198
271 HERNIA 383 0.0198
272 ARTHRITIS 1558 0.0198
273 LIVER FUNCTION TEST INCREASED 425 0.0198
274 SKIN INFECTION 222 0.0198
275 LARGE INTESTINE PERFORATION 137 0.0197
276 SKIN ABRASION 93 0.0197
277 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1398 0.0196
278 BACTERIAL SEPSIS 64 0.0196
279 SKIN LACERATION 213 0.0196
280 NEPHROLITHIASIS 897 0.0195
281 FISTULA 219 0.0195
282 PYODERMA GANGRENOSUM 70 0.0194
283 MUSCULOSKELETAL STIFFNESS 1701 0.0194
284 GASTROINTESTINAL INFECTION 174 0.0194
285 OFF LABEL USE 16904 0.0193
286 CHOLECYSTECTOMY 220 0.0192
287 GASTROINTESTINAL MOTILITY DISORDER 103 0.0192
288 CORONAVIRUS INFECTION 127 0.0192
289 SYSTEMIC LUPUS ERYTHEMATOSUS 681 0.0192
290 APHTHOUS ULCER 148 0.0191
291 INTERNAL HAEMORRHAGE 218 0.0191
292 IMMUNE SYSTEM DISORDER 250 0.0190
293 TOOTH INFECTION 250 0.0189
294 ABSCESS 302 0.0189
295 TRANSFUSION 198 0.0189
296 MYOSITIS 169 0.0188
297 POLYARTHRITIS 99 0.0188
298 SKIN LESION 513 0.0187
299 POST PROCEDURAL COMPLICATION 358 0.0186
300 ULCER HAEMORRHAGE 126 0.0186
301 MUSCLE INJURY 154 0.0186
302 EPSTEIN-BARR VIRUS INFECTION 116 0.0185
303 THERAPEUTIC PRODUCT EFFECT DELAYED 84 0.0184
304 APPENDICITIS 172 0.0184
305 LOW DENSITY LIPOPROTEIN INCREASED 142 0.0183
306 ULCER 291 0.0183
307 SPINAL DISORDER 173 0.0182
308 GASTROINTESTINAL INFLAMMATION 143 0.0182
309 HYPERURICAEMIA 75 0.0182
310 LEUKOCYTOSIS 330 0.0182
311 ABDOMINAL ABSCESS 80 0.0181
312 HYPERCHOLESTEROLAEMIA 174 0.0180
313 BACTERIAL INFECTION 336 0.0180
314 INCREASED APPETITE 344 0.0180
315 PROCEDURAL PAIN 498 0.0179
316 SCLERODERMA 65 0.0179
317 JOINT STIFFNESS 469 0.0179
318 SPINAL OSTEOARTHRITIS 157 0.0179
319 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 116 0.0178
320 CLOSTRIDIUM DIFFICILE INFECTION 387 0.0177
321 ANKLE FRACTURE 274 0.0177
322 VITREOUS FLOATERS 174 0.0177
323 PRODUCT STORAGE ISSUE 67 0.0177
324 PULMONARY FIBROSIS 339 0.0177
325 DIARRHOEA HAEMORRHAGIC 164 0.0175
326 LIGAMENT SPRAIN 173 0.0175
327 COLITIS 658 0.0173
328 CHRONIC MYELOID LEUKAEMIA 80 0.0173
329 PERIPHERAL SWELLING 2666 0.0173
330 LIMB INJURY 469 0.0172
331 HIP FRACTURE 555 0.0172
332 STAPHYLOCOCCAL INFECTION 568 0.0172
333 DERMATITIS ACNEIFORM 104 0.0171
334 JOINT INJURY 364 0.0170
335 MUCOUS STOOLS 84 0.0169
336 MASS 237 0.0169
337 KIDNEY INFECTION 330 0.0168
338 LUMBAR VERTEBRAL FRACTURE 77 0.0168
339 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 120 0.0167
340 WRIST FRACTURE 200 0.0167
341 BLOOD LACTATE DEHYDROGENASE INCREASED 263 0.0166
342 IRON DEFICIENCY ANAEMIA 153 0.0166
343 ORGANISING PNEUMONIA 82 0.0165
344 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 789 0.0164
345 SKIN ULCER 424 0.0164
346 DUODENAL ULCER PERFORATION 121 0.0163
347 SPINAL FRACTURE 326 0.0163
348 LOWER LIMB FRACTURE 312 0.0162
349 BACTERAEMIA 192 0.0162
350 URINARY TRACT INFECTION 2757 0.0161
351 ANKYLOSING SPONDYLITIS 213 0.0161
352 PERIPHERAL VENOUS DISEASE 66 0.0161
353 FREQUENT BOWEL MOVEMENTS 436 0.0161
354 INFECTION 2336 0.0161
355 VIRAL INFECTION 536 0.0161
356 INFLUENZA 1796 0.0161
357 PSORIATIC ARTHROPATHY 652 0.0160
358 MOBILITY DECREASED 1148 0.0160
359 PULMONARY TUBERCULOSIS 68 0.0159
360 ILL-DEFINED DISORDER 966 0.0159
361 SKIN MASS 106 0.0159
362 EAR INFECTION 422 0.0158
363 HEPATIC ENZYME ABNORMAL 79 0.0158
364 FOOT FRACTURE 300 0.0158
365 BACK INJURY 172 0.0158
366 ESCHERICHIA INFECTION 130 0.0158
367 FURUNCLE 125 0.0158
368 GASTROENTERITIS VIRAL 284 0.0157
369 HELICOBACTER INFECTION 160 0.0156
370 RIB FRACTURE 318 0.0154
371 ARTHRALGIA 6426 0.0154
372 FIBROMYALGIA 375 0.0154
373 STRESS FRACTURE 83 0.0154
374 CARDIAC OPERATION 132 0.0153
375 AUTOIMMUNE DISORDER 149 0.0153
376 UROSEPSIS 141 0.0153
377 SPINAL PAIN 179 0.0153
378 BURSITIS 185 0.0152
379 THROMBOSIS 1223 0.0152
380 FLUID INTAKE REDUCED 76 0.0152
381 PAPULE 107 0.0152
382 JOINT SWELLING 1826 0.0151
383 FOOD POISONING 81 0.0151
384 UPPER LIMB FRACTURE 301 0.0151
385 UPPER RESPIRATORY TRACT INFECTION 698 0.0151
386 EYE INFECTION 170 0.0150
387 PSEUDOMONAS INFECTION 129 0.0150
388 SUBCUTANEOUS ABSCESS 72 0.0150
389 INTERVERTEBRAL DISC DISORDER 64 0.0150
390 THERAPEUTIC RESPONSE UNEXPECTED 672 0.0150
391 SKIN ATROPHY 86 0.0149
392 HYPOGAMMAGLOBULINAEMIA 97 0.0148
393 BLOOD PRESSURE ABNORMAL 293 0.0147
394 BONE PAIN 863 0.0147
395 HUMERUS FRACTURE 71 0.0147
396 BLOOD POTASSIUM INCREASED 238 0.0146
397 ACCIDENT 175 0.0146
398 KLEBSIELLA INFECTION 74 0.0146
399 ECZEMA 765 0.0146
400 PHARYNGITIS STREPTOCOCCAL 157 0.0145
401 PULMONARY MASS 216 0.0145
402 BRAIN FOG 227 0.0145
403 SCAB 165 0.0145
404 LARGE INTESTINE POLYP 100 0.0144
405 ONYCHOCLASIS 99 0.0144
406 BLOOD TRIGLYCERIDES INCREASED 254 0.0144
407 POLYP 94 0.0143
408 PAIN IN EXTREMITY 4222 0.0143
409 HEPATIC ENZYME INCREASED 969 0.0142
410 CORONARY ARTERIAL STENT INSERTION 72 0.0142
411 HIATUS HERNIA 183 0.0141
412 SEPSIS 1569 0.0141
413 ARTHROPOD BITE 104 0.0140
414 GASTROINTESTINAL PAIN 154 0.0140
415 WEIGHT INCREASED 3127 0.0139
416 CYSTITIS 443 0.0139
417 UMBILICAL HERNIA 65 0.0139
418 SKIN HAEMORRHAGE 206 0.0139
419 RESPIRATORY TRACT INFECTION 362 0.0139
420 SINUSITIS 1422 0.0139
421 WOUND 387 0.0138
422 MOUTH ULCERATION 291 0.0138
423 NODULE 180 0.0138
424 VENOOCCLUSIVE LIVER DISEASE 68 0.0138
425 FLATULENCE 779 0.0137
426 THERAPY PARTIAL RESPONDER 214 0.0137
427 INFLAMMATORY BOWEL DISEASE 134 0.0137
428 VITAMIN D DECREASED 117 0.0137
429 ABNORMAL FAECES 112 0.0137
430 ORAL DISORDER 100 0.0136
431 NEOPLASM MALIGNANT 910 0.0136
432 EPISTAXIS 1017 0.0136
433 PNEUMONIA 4392 0.0136
434 HAEMATOCHEZIA 748 0.0135
435 SMALL INTESTINAL OBSTRUCTION 166 0.0135
436 GASTROINTESTINAL DISORDER 1203 0.0134
437 HAND DEFORMITY 176 0.0134
438 NEUTROPHIL COUNT INCREASED 137 0.0134
439 STOMATITIS 810 0.0133
440 DIZZINESS POSTURAL 129 0.0133
441 THROMBOCYTOPENIA 1485 0.0133
442 UNEVALUABLE EVENT 1001 0.0132
443 RENAL CYST 105 0.0132
444 PROCTALGIA 85 0.0132
445 STAPHYLOCOCCAL SEPSIS 65 0.0132
446 NASOPHARYNGITIS 2422 0.0131
447 ACUTE RESPIRATORY FAILURE 252 0.0131
448 C-REACTIVE PROTEIN ABNORMAL 84 0.0131
449 INTESTINAL OBSTRUCTION 493 0.0131
450 MULTIPLE ORGAN DYSFUNCTION SYNDROME 369 0.0130
451 ANAL INCONTINENCE 117 0.0130
452 EMBOLISM 108 0.0130
453 ENTERITIS 83 0.0130
454 COLON CANCER 193 0.0129
455 BLOOD SODIUM DECREASED 244 0.0129
456 MUSCULOSKELETAL CHEST PAIN 200 0.0129
457 SCOLIOSIS 80 0.0129
458 TOOTH FRACTURE 142 0.0129
459 TERMINAL STATE 86 0.0128
460 CANDIDA INFECTION 216 0.0128
461 VARICOSE VEIN 66 0.0128
462 DISABILITY 252 0.0127
463 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 699 0.0127
464 DEAFNESS UNILATERAL 70 0.0127
465 APPETITE DISORDER 84 0.0127
466 ORAL CANDIDIASIS 166 0.0126
467 SYNOVITIS 227 0.0126
468 FALL 4186 0.0126
469 FEEDING DISORDER 255 0.0126
470 LYMPHOMA 194 0.0125
471 TOOTH EXTRACTION 156 0.0125
472 WHITE BLOOD CELL COUNT DECREASED 1353 0.0125
473 PAIN 7546 0.0123
474 MENINGITIS 82 0.0123
475 SINUS DISORDER 241 0.0122
476 BREAST CANCER STAGE II 101 0.0121
477 TENDON DISORDER 79 0.0121
478 HYPERTRANSAMINASAEMIA 84 0.0121
479 SKIN DISCOLOURATION 555 0.0121
480 CELLULITIS 608 0.0121
481 INTENTIONAL DOSE OMISSION 343 0.0120
482 PYELONEPHRITIS 104 0.0120
483 RESPIRATORY TRACT CONGESTION 190 0.0119
484 RESPIRATORY DISORDER 357 0.0119
485 BRONCHITIS 883 0.0119
486 PIGMENTATION DISORDER 73 0.0118
487 FATIGUE 9188 0.0118
488 RED BLOOD CELL SEDIMENTATION RATE INCREASED 130 0.0117
489 PNEUMOTHORAX 185 0.0117
490 SCRATCH 123 0.0116
491 BACK PAIN 2708 0.0116
492 FUNGAL INFECTION 387 0.0116
493 POST PROCEDURAL HAEMORRHAGE 135 0.0116
494 ARTERIAL OCCLUSIVE DISEASE 91 0.0116
495 DYSPNOEA EXERTIONAL 435 0.0115
496 GLUCOSE TOLERANCE IMPAIRED 68 0.0115
497 HEAD INJURY 362 0.0114
498 BREAST CANCER FEMALE 305 0.0114
499 SWELLING 1066 0.0114
500 SPINAL COMPRESSION FRACTURE 94 0.0114
501 MUSCULOSKELETAL DISCOMFORT 195 0.0113
502 BREAST MASS 76 0.0113
503 HAND FRACTURE 80 0.0113
504 STENT PLACEMENT 91 0.0113
505 HEPATIC STEATOSIS 210 0.0113
506 NECK PAIN 627 0.0112
507 OSTEOPOROSIS 461 0.0112
508 PULMONARY EMBOLISM 1064 0.0112
509 TOOTH ABSCESS 113 0.0111
510 LYMPHOCYTE COUNT DECREASED 196 0.0111
511 PERICARDITIS 186 0.0111
512 RENAL DISORDER 511 0.0110
513 LUNG DISORDER 537 0.0109
514 MEMORY IMPAIRMENT 1502 0.0109
515 FRUSTRATION TOLERANCE DECREASED 88 0.0109
516 POOR QUALITY SLEEP 234 0.0109
517 ECCHYMOSIS 74 0.0108
518 BONE DISORDER 196 0.0107
519 RASH PAPULAR 241 0.0107
520 FAECES SOFT 78 0.0107
521 GROIN PAIN 94 0.0107
522 SCAR 183 0.0107
523 DYSSTASIA 311 0.0106
524 DIFFUSE LARGE B-CELL LYMPHOMA 82 0.0106
525 MOUTH HAEMORRHAGE 78 0.0106
526 LIVE BIRTH 89 0.0106
527 LIVER INJURY 261 0.0106
528 ABDOMINAL DISTENSION 1105 0.0106
529 C-REACTIVE PROTEIN INCREASED 385 0.0106
530 MACULAR DEGENERATION 126 0.0105
531 HAEMATOMA 273 0.0105
532 NEURALGIA 256 0.0105
533 BLISTER 591 0.0105
534 HEPATIC CIRRHOSIS 197 0.0105
535 HIDRADENITIS 95 0.0104
536 CONCUSSION 80 0.0103
537 FLUID RETENTION 525 0.0103
538 ROAD TRAFFIC ACCIDENT 430 0.0103
539 SEASONAL ALLERGY 145 0.0102
540 MULTIPLE ALLERGIES 80 0.0102
541 HYPOPHAGIA 260 0.0102
542 THERAPY CHANGE 100 0.0102
543 TRANSIENT ISCHAEMIC ATTACK 343 0.0102
544 OSTEOMYELITIS 184 0.0102
545 BOWEL MOVEMENT IRREGULARITY 77 0.0100
546 DEATH 8644 0.0100
547 IRRITABLE BOWEL SYNDROME 215 0.0100
548 ASTHENIA 3770 0.0100
549 GASTROENTERITIS 146 0.0100
550 MYOPATHY 86 0.0099
551 EAR PAIN 193 0.0099
552 CLOSTRIDIUM DIFFICILE COLITIS 105 0.0099
553 RESPIRATION ABNORMAL 68 0.0099
554 HAEMORRHAGE 1031 0.0099
555 DIVERTICULUM 70 0.0098
556 DISCOMFORT 600 0.0098
557 NEOPLASM 113 0.0098
558 FEMUR FRACTURE 304 0.0098
559 LIMB DISCOMFORT 301 0.0097
560 THERAPY NON-RESPONDER 437 0.0097
561 NAIL DISORDER 85 0.0097
562 HYPERSOMNIA 278 0.0097
563 BLADDER DISORDER 96 0.0097
564 GASTRIC HAEMORRHAGE 111 0.0096
565 CORONARY ARTERY OCCLUSION 132 0.0096
566 FAECES DISCOLOURED 208 0.0096
567 PULMONARY HAEMORRHAGE 75 0.0096
568 SEPTIC SHOCK 417 0.0096
569 CHOLELITHIASIS 313 0.0095
570 SKIN FISSURES 186 0.0095
571 OROPHARYNGEAL PAIN 879 0.0095
572 LUPUS-LIKE SYNDROME 86 0.0095
573 UPPER-AIRWAY COUGH SYNDROME 78 0.0095
574 AORTIC ANEURYSM 72 0.0095
575 CEREBRAL DISORDER 70 0.0095
576 BEDRIDDEN 124 0.0094
577 HAEMORRHOIDS 184 0.0094
578 GAIT DISTURBANCE 1800 0.0094
579 ENCEPHALITIS 65 0.0094
580 LIVER DISORDER 415 0.0093
581 LYMPHADENOPATHY 331 0.0093
582 PRODUCT DOSE OMISSION ISSUE 2749 0.0093
583 PANCYTOPENIA 522 0.0093
584 SLUGGISHNESS 95 0.0093
585 FEELING COLD 259 0.0093
586 RASH MACULAR 325 0.0093
587 INSURANCE ISSUE 142 0.0093
588 PEMPHIGUS 116 0.0093
589 ABDOMINAL PAIN 2156 0.0093
590 GLAUCOMA 178 0.0092
591 GINGIVAL BLEEDING 126 0.0092
592 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 270 0.0092
593 NERVE INJURY 102 0.0092
594 MUSCLE SPASMS 1682 0.0092
595 PYREXIA 3159 0.0091
596 PETECHIAE 95 0.0091
597 THYROID DISORDER 140 0.0091
598 BLOOD URINE PRESENT 172 0.0091
599 APHONIA 126 0.0090
600 BLOOD POTASSIUM DECREASED 271 0.0090
601 PROCEDURAL COMPLICATION 69 0.0090
602 ABDOMINAL DISCOMFORT 1506 0.0090
603 PULMONARY HYPERTENSION 187 0.0090
604 RENAL PAIN 95 0.0090
605 SECRETION DISCHARGE 112 0.0089
606 UTERINE LEIOMYOMA 65 0.0089
607 TENDONITIS 136 0.0088
608 DERMATITIS 184 0.0088
609 BLOOD BILIRUBIN INCREASED 236 0.0087
610 POLLAKIURIA 364 0.0087
611 ACUTE RESPIRATORY DISTRESS SYNDROME 154 0.0087
612 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 83 0.0087
613 FOOD ALLERGY 67 0.0087
614 GINGIVAL PAIN 69 0.0087
615 SINUS CONGESTION 117 0.0087
616 DEAFNESS 226 0.0086
617 LYMPHOPENIA 122 0.0086
618 OVARIAN CYST 86 0.0086
619 DEEP VEIN THROMBOSIS 559 0.0086
620 GASTRITIS 226 0.0086
621 GASTRIC ULCER 163 0.0086
622 MYELODYSPLASTIC SYNDROME 124 0.0086
623 CARDIAC DISORDER 800 0.0085
624 GASTRIC DISORDER 293 0.0085
625 GLOSSODYNIA 191 0.0085
626 CONDITION AGGRAVATED 2587 0.0085
627 ORAL PAIN 190 0.0085
628 CONSTIPATION 1835 0.0084
629 FACIAL PAIN 75 0.0084
630 TOOTH DISORDER 186 0.0084
631 BLOOD UREA INCREASED 140 0.0084
632 EYE DISORDER 273 0.0083
633 HOSPICE CARE 82 0.0083
634 PRURITUS 3188 0.0083
635 ADVERSE DRUG REACTION 745 0.0083
636 DISEASE PROGRESSION 980 0.0083
637 BRAIN NEOPLASM 76 0.0083
638 DEVICE RELATED INFECTION 127 0.0082
639 COUGH 2312 0.0082
640 OSTEOPENIA 125 0.0082
641 ABDOMINAL PAIN UPPER 1683 0.0082
642 INTENTIONAL PRODUCT USE ISSUE 716 0.0082
643 PERIPHERAL COLDNESS 112 0.0081
644 HYPOAESTHESIA 1220 0.0081
645 MUSCLE ATROPHY 103 0.0081
646 SLEEP DISORDER 573 0.0081
647 INTERSTITIAL LUNG DISEASE 393 0.0081
648 BLOOD MAGNESIUM DECREASED 70 0.0081
649 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 423 0.0081
650 BALANCE DISORDER 700 0.0081
651 TOOTHACHE 146 0.0081
652 ATRIAL FIBRILLATION 784 0.0080
653 OEDEMA 435 0.0080
654 CHILLS 939 0.0080
655 EAR DISCOMFORT 82 0.0080
656 DIZZINESS 3978 0.0080
657 PULMONARY OEDEMA 357 0.0080
658 DYSURIA 293 0.0080
659 FEBRILE NEUTROPENIA 525 0.0079
660 GLOMERULAR FILTRATION RATE DECREASED 97 0.0079
661 EYE DISCHARGE 82 0.0079
662 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1421 0.0079
663 GALLBLADDER DISORDER 140 0.0078
664 EATING DISORDER 166 0.0078
665 FLANK PAIN 73 0.0078
666 RESPIRATORY FAILURE 567 0.0078
667 EYE HAEMORRHAGE 103 0.0077
668 GENERAL PHYSICAL HEALTH DETERIORATION 893 0.0077
669 CONJUNCTIVITIS 143 0.0077
670 LOWER RESPIRATORY TRACT INFECTION 349 0.0077
671 EYE INFLAMMATION 73 0.0076
672 DRY EYE 381 0.0076
673 HUNGER 106 0.0076
674 PULMONARY CONGESTION 100 0.0076
675 DRY THROAT 77 0.0076
676 NEUROPATHY PERIPHERAL 720 0.0076
677 RECTAL HAEMORRHAGE 325 0.0076
678 THERAPY CESSATION 388 0.0076
679 WEIGHT FLUCTUATION 79 0.0075
680 DRUG DOSE OMISSION 1247 0.0075
681 HYPOACUSIS 324 0.0075
682 REBOUND EFFECT 85 0.0075
683 DRUG RESISTANCE 193 0.0075
684 MALNUTRITION 84 0.0075
685 COAGULOPATHY 125 0.0075
686 DYSPEPSIA 738 0.0075
687 MALAISE 3289 0.0075
688 CHEST PAIN 1384 0.0075
689 LOSS OF CONSCIOUSNESS 957 0.0075
690 PAIN OF SKIN 200 0.0074
691 DRUG EFFECT LESS THAN EXPECTED 110 0.0074
692 HYPERTENSION 1572 0.0074
693 NOCTURIA 90 0.0074
694 WEIGHT DECREASED 2066 0.0074
695 ASPARTATE AMINOTRANSFERASE INCREASED 393 0.0074
696 FRACTURE 140 0.0074
697 HEADACHE 4618 0.0074
698 PHARYNGEAL SWELLING 72 0.0074
699 VERTIGO 444 0.0073
700 OSTEONECROSIS 239 0.0073
701 HOSPITALISATION 1117 0.0073
702 MICTURITION URGENCY 83 0.0073
703 DIARRHOEA 4683 0.0072
704 LUNG INFILTRATION 64 0.0072
705 GASTROINTESTINAL HAEMORRHAGE 605 0.0072
706 MIGRAINE 690 0.0072
707 DEHYDRATION 960 0.0072
708 FEELING ABNORMAL 1720 0.0072
709 ACUTE MYOCARDIAL INFARCTION 211 0.0071
710 ALANINE AMINOTRANSFERASE INCREASED 437 0.0071
711 HEAD DISCOMFORT 126 0.0071
712 IMPAIRED QUALITY OF LIFE 102 0.0071
713 DENTAL CARIES 78 0.0070
714 BLINDNESS UNILATERAL 99 0.0070
715 OESOPHAGITIS 76 0.0069
716 TRANSAMINASES INCREASED 154 0.0069
717 MUCOSAL INFLAMMATION 181 0.0069
718 BLINDNESS 281 0.0069
719 HAEMOPTYSIS 192 0.0069
720 TEMPERATURE INTOLERANCE 71 0.0069
721 DRUG INTOLERANCE 663 0.0069
722 MUSCULAR WEAKNESS 779 0.0068
723 BLOOD CALCIUM DECREASED 77 0.0068
724 OXYGEN SATURATION DECREASED 383 0.0068
725 GENERALISED OEDEMA 84 0.0068
726 RASH 2949 0.0068
727 PERICARDIAL EFFUSION 156 0.0067
728 ARTERIOSCLEROSIS 63 0.0067
729 LUNG NEOPLASM MALIGNANT 275 0.0067
730 VISUAL IMPAIRMENT 822 0.0066
731 DECREASED APPETITE 1540 0.0066
732 HYPERLIPIDAEMIA 79 0.0066
733 HYPOXIA 231 0.0066
734 SLEEP APNOEA SYNDROME 125 0.0065
735 BONE MARROW FAILURE 133 0.0065
736 MOVEMENT DISORDER 210 0.0065
737 TYPE 2 DIABETES MELLITUS 220 0.0065
738 PHARYNGITIS 81 0.0065
739 TENDERNESS 68 0.0065
740 CEREBROVASCULAR ACCIDENT 1096 0.0065
741 BLOOD CREATININE INCREASED 422 0.0065
742 SKIN EXFOLIATION 544 0.0064
743 DYSPNOEA 3623 0.0064
744 AMNESIA 416 0.0064
745 BODY TEMPERATURE INCREASED 130 0.0064
746 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 108 0.0064
747 VASCULITIS 74 0.0063
748 TREATMENT FAILURE 526 0.0063
749 INITIAL INSOMNIA 65 0.0063
750 OCULAR DISCOMFORT 71 0.0063
751 CEREBRAL HAEMORRHAGE 226 0.0063
752 RASH PRURITIC 342 0.0063
753 MUSCLE TIGHTNESS 102 0.0063
754 ABDOMINAL PAIN LOWER 159 0.0063
755 DEPRESSED MOOD 331 0.0063
756 PRODUCT DISPENSING ERROR 136 0.0062
757 THYROID CANCER 75 0.0062
758 GASTROOESOPHAGEAL REFLUX DISEASE 501 0.0062
759 BLOOD CREATINE PHOSPHOKINASE INCREASED 179 0.0062
760 BURNING SENSATION 433 0.0062
761 DYSPHONIA 361 0.0062
762 RENAL IMPAIRMENT 517 0.0061
763 PALLOR 167 0.0061
764 CARDIOMEGALY 75 0.0061
765 HEPATITIS 156 0.0061
766 DIABETES MELLITUS 463 0.0061
767 RHINORRHOEA 392 0.0061
768 ALOPECIA 1191 0.0061
769 TASTE DISORDER 123 0.0061
770 DELIRIUM 210 0.0060
771 HAEMATEMESIS 153 0.0060
772 TINNITUS 277 0.0060
773 LEUKOPENIA 301 0.0060
774 PRODUCT USE IN UNAPPROVED INDICATION 1481 0.0060
775 PRODUCTIVE COUGH 285 0.0060
776 PANCREATITIS 315 0.0060
777 PNEUMONITIS 162 0.0059
778 NASAL CONGESTION 348 0.0059
779 DRY MOUTH 479 0.0059
780 MATERNAL EXPOSURE DURING PREGNANCY 524 0.0059
781 CARDIOVASCULAR DISORDER 149 0.0059
782 MELAENA 129 0.0059
783 PRODUCT PHYSICAL ISSUE 118 0.0058
784 PLEURAL EFFUSION 355 0.0058
785 PANCREATITIS ACUTE 131 0.0058
786 PRODUCT USE COMPLAINT 91 0.0058
787 DRUG INEFFECTIVE 7606 0.0058
788 HYPERHIDROSIS 743 0.0058
789 MENTAL STATUS CHANGES 160 0.0058
790 ORAL DISCOMFORT 80 0.0058
791 UVEITIS 78 0.0057
792 PSORIASIS 748 0.0057
793 NEUTROPHIL COUNT DECREASED 233 0.0057
794 ISCHAEMIC STROKE 102 0.0057
795 BLOOD PRESSURE FLUCTUATION 137 0.0057
796 DEMENTIA 159 0.0057
797 MYALGIA 967 0.0057
798 CARDIAC FAILURE CONGESTIVE 455 0.0057
799 PRODUCT PRESCRIBING ISSUE 122 0.0056
800 INSOMNIA 1488 0.0056
801 EYE SWELLING 207 0.0056
802 SWELLING FACE 361 0.0055
803 FEELING HOT 338 0.0055
804 DRY SKIN 730 0.0055
805 OBESITY 87 0.0055
806 CHROMATURIA 123 0.0054
807 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1102 0.0054
808 DYSPHAGIA 516 0.0054
809 IMPAIRED WORK ABILITY 116 0.0054
810 APHASIA 163 0.0054
811 QUALITY OF LIFE DECREASED 72 0.0054
812 CARDIAC FAILURE 429 0.0053
813 NAUSEA 4216 0.0053
814 OEDEMA PERIPHERAL 643 0.0053
815 HEART RATE DECREASED 184 0.0052
816 VOMITING 2460 0.0052
817 PARAESTHESIA 819 0.0052
818 MENTAL DISORDER 226 0.0052
819 ADRENAL INSUFFICIENCY 63 0.0052
820 ASCITES 152 0.0052
821 DERMATITIS ALLERGIC 65 0.0052
822 GAMMA-GLUTAMYLTRANSFERASE INCREASED 114 0.0051
823 ANGINA PECTORIS 147 0.0051
824 PHOTOPHOBIA 96 0.0051
825 BLOOD GLUCOSE ABNORMAL 94 0.0051
826 MUSCULOSKELETAL PAIN 266 0.0051
827 BLOOD ALKALINE PHOSPHATASE INCREASED 126 0.0051
828 COLD SWEAT 89 0.0050
829 THERAPEUTIC RESPONSE SHORTENED 167 0.0050
830 DISEASE RECURRENCE 239 0.0050
831 EMOTIONAL DISORDER 154 0.0050
832 ERUCTATION 96 0.0050
833 LIVER FUNCTION TEST ABNORMAL 144 0.0049
834 UPPER GASTROINTESTINAL HAEMORRHAGE 83 0.0049
835 SYNCOPE 491 0.0049
836 CORONARY ARTERY DISEASE 148 0.0049
837 SPEECH DISORDER 256 0.0049
838 THINKING ABNORMAL 91 0.0049
839 HEPATIC FUNCTION ABNORMAL 182 0.0049
840 NEUTROPENIA 663 0.0049
841 DEPRESSION 1107 0.0049
842 VISION BLURRED 662 0.0048
843 MIDDLE INSOMNIA 90 0.0048
844 MYOCARDIAL INFARCTION 837 0.0048
845 RASH ERYTHEMATOUS 229 0.0048
846 PRODUCT PRESCRIBING ERROR 114 0.0048
847 RENAL FAILURE 635 0.0048
848 SOMNOLENCE 951 0.0047
849 PALPITATIONS 553 0.0047
850 HEPATIC FAILURE 142 0.0047
851 DRUG-INDUCED LIVER INJURY 147 0.0047
852 PNEUMONIA ASPIRATION 117 0.0047
853 CHEST DISCOMFORT 479 0.0047
854 HAEMATURIA 160 0.0047
855 HEART RATE INCREASED 462 0.0047
856 HEPATOTOXICITY 103 0.0046
857 URINARY INCONTINENCE 137 0.0046
858 ERYTHEMA 950 0.0046
859 RESTLESS LEGS SYNDROME 84 0.0046
860 PAIN IN JAW 130 0.0046
861 LACRIMATION INCREASED 138 0.0046
862 ASTHMA 516 0.0046
863 PARALYSIS 65 0.0045
864 ACUTE KIDNEY INJURY 694 0.0045
865 THIRST 81 0.0045
866 CHOKING 88 0.0045
867 AGEUSIA 112 0.0045
868 HYPOTHYROIDISM 143 0.0045
869 BLOOD PRESSURE INCREASED 683 0.0045
870 SNEEZING 100 0.0045
871 INFLUENZA LIKE ILLNESS 362 0.0044
872 LETHARGY 253 0.0044
873 SEIZURE 506 0.0044
874 CONFUSIONAL STATE 701 0.0043
875 THROAT IRRITATION 192 0.0043
876 EPILEPSY 130 0.0042
877 PHOTOSENSITIVITY REACTION 70 0.0042
878 NERVOUS SYSTEM DISORDER 131 0.0042
879 EYE PRURITUS 139 0.0041
880 URTICARIA 685 0.0041
881 HYPERSENSITIVITY 759 0.0041
882 HOT FLUSH 308 0.0041
883 DIPLOPIA 106 0.0041
884 INJURY 285 0.0041
885 DISTURBANCE IN ATTENTION 217 0.0040
886 PERITONITIS 83 0.0040
887 TACHYCARDIA 356 0.0040
888 DRUG ERUPTION 71 0.0040
889 MENTAL IMPAIRMENT 97 0.0040
890 WHEEZING 237 0.0040
891 PRESYNCOPE 97 0.0040
892 URINARY RETENTION 133 0.0040
893 CEREBRAL INFARCTION 97 0.0040
894 HYPOTENSION 792 0.0039
895 RETCHING 84 0.0039
896 HEART RATE IRREGULAR 89 0.0039
897 PRESCRIBED OVERDOSE 76 0.0039
898 EYE PAIN 221 0.0039
899 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 278 0.0039
900 THERAPEUTIC RESPONSE DECREASED 234 0.0039
901 INCORRECT DOSE ADMINISTERED 880 0.0039
902 CHRONIC KIDNEY DISEASE 288 0.0038
903 MYELOSUPPRESSION 135 0.0037
904 AMENORRHOEA 65 0.0037
905 BLOOD PRESSURE DECREASED 245 0.0037
906 ANXIETY 1043 0.0037
907 TREATMENT NONCOMPLIANCE 200 0.0037
908 HYPERKALAEMIA 127 0.0036
909 PROSTATE CANCER 291 0.0036
910 NERVOUSNESS 189 0.0036
911 CYTOKINE RELEASE SYNDROME 72 0.0036
912 RESPIRATORY DISTRESS 99 0.0036
913 COGNITIVE DISORDER 166 0.0036
914 ARRHYTHMIA 168 0.0035
915 INTENTIONAL PRODUCT MISUSE 310 0.0035
916 PRODUCT USE ISSUE 662 0.0035
917 TOOTH LOSS 73 0.0035
918 ENCEPHALOPATHY 86 0.0035
919 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
920 JAUNDICE 93 0.0035
921 SKIN IRRITATION 158 0.0034
922 SHOCK 79 0.0034
923 SWOLLEN TONGUE 107 0.0034
924 TREMOR 563 0.0034
925 PANIC ATTACK 123 0.0034
926 PANCREATIC CARCINOMA 97 0.0034
927 BLOOD GLUCOSE DECREASED 161 0.0033
928 OCULAR HYPERAEMIA 159 0.0033
929 DISORIENTATION 131 0.0033
930 CARDIAC ARREST 266 0.0032
931 LIP SWELLING 106 0.0032
932 SKIN BURNING SENSATION 226 0.0032
933 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 73 0.0031
934 HYPOKALAEMIA 143 0.0031
935 BREAST CANCER 286 0.0031
936 HYPONATRAEMIA 168 0.0030
937 PRODUCT STORAGE ERROR 260 0.0030
938 ABORTION SPONTANEOUS 119 0.0030
939 MUSCLE TWITCHING 67 0.0029
940 GLYCOSYLATED HAEMOGLOBIN INCREASED 73 0.0029
941 CRYING 105 0.0029
942 DYSARTHRIA 108 0.0029
943 MALIGNANT NEOPLASM PROGRESSION 287 0.0028
944 DRUG INTERACTION 442 0.0028
945 FEAR 73 0.0027
946 CONTRAINDICATED PRODUCT ADMINISTERED 82 0.0027
947 GASTRIC CANCER 68 0.0027
948 ANAPHYLACTIC REACTION 148 0.0027
949 MOOD ALTERED 73 0.0027
950 SUICIDAL IDEATION 244 0.0027
951 HYPERGLYCAEMIA 97 0.0027
952 THROAT TIGHTNESS 72 0.0027
953 ABNORMAL DREAMS 73 0.0026
954 EXTRA DOSE ADMINISTERED 106 0.0026
955 INFUSION RELATED REACTION 166 0.0025
956 RHABDOMYOLYSIS 103 0.0025
957 MEDICATION ERROR 135 0.0024
958 DYSGEUSIA 179 0.0024
959 WITHDRAWAL SYNDROME 94 0.0022
960 MULTIPLE SCLEROSIS 106 0.0022
961 BLADDER CANCER 126 0.0021
962 CARDIO-RESPIRATORY ARREST 89 0.0021
963 MOOD SWINGS 66 0.0021
964 COMA 97 0.0020
965 ANGER 68 0.0020
966 HYPOGLYCAEMIA 97 0.0020
967 BLOOD GLUCOSE INCREASED 369 0.0020
968 EYE IRRITATION 112 0.0019
969 IRRITABILITY 117 0.0019
970 TOXICITY TO VARIOUS AGENTS 324 0.0019
971 RENAL CANCER 91 0.0019
972 ADVERSE EVENT 172 0.0019
973 NIGHTMARE 64 0.0018
974 BRADYCARDIA 91 0.0017
975 VAGINAL HAEMORRHAGE 74 0.0017
976 HALLUCINATION 115 0.0015
977 DEVICE DISLOCATION 66 0.0015
978 FOETAL EXPOSURE DURING PREGNANCY 112 0.0014
979 AGITATION 95 0.0013
980 NO ADVERSE EVENT 209 0.0012
981 FLUSHING 104 0.0010
982 INJECTION SITE REACTION 67 0.0010
983 INJECTION SITE BRUISING 72 0.0009
984 INJECTION SITE SWELLING 68 0.0009
985 EMOTIONAL DISTRESS 93 0.0008
986 DEVICE ISSUE 68 0.0008
987 INJECTION SITE ERYTHEMA 84 0.0007
988 INJECTION SITE PAIN 198 0.0006
989 OVERDOSE 96 0.0004